Source:http://linkedlifedata.com/resource/pubmed/id/12444323
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2002-11-21
|
| pubmed:abstractText |
Sublingual immunotherapy (SLIT) has been demonstrated to be a viable alternative to injection immunotherapy. Administration of high doses of allergens to ensure efficacy has been shown to be well tolerated. The aim of the present study was the first step to address the issue of fast-induction regimens using various induction SLIT regimens in paediatric and adult patients.
|
| pubmed:language |
eng
|
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:author | |
| pubmed:copyrightInfo |
Copyright 2002 S. Karger AG, Basel
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
248-53
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:articleTitle |
Safety of various dosage regimens during induction of sublingual immunotherapy. A preliminary study.
|
| pubmed:affiliation |
Guilleret-Granges, France.
|